Muhammad Hameed
NPI 1851556062 · Medical Oncology Physician · Kalamazoo, MI
Enrolled with Medicare as Practitioner - Medical Oncology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1851556062
- Entity type
- Individual
- Primary specialty
- Medical Oncology PhysicianAllopathic & Osteopathic Physicians
- Sex
- Male
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
17 yrs in NPPES registry
- Profile completeness28% of score
83% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
4,181 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Complete Blood Cell Count (red Cells, White Blood Cell, Platelets), Automated Test and Automated Differential White Blood Cell Count85025 | 769 | $7 |
| Blood Test, Comprehensive Group of Blood Chemicals80053 | 630 | $10 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 420 | $91 |
| Administration of Chemotherapy Into Vein, 1 Hour Or Less96413 | 253 | $109 |
| Injection of Drug Or Substance Under Skin Or Into Muscle96372 | 235 | $13 |
| Gammaglobulin (immune System Protein) Measurement82784 | 157 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 28 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Abiraterone Acetate | 122 | 17 |
| Prednisone | 71 | 37 |
| Enzalutamidebrand: Xtandi | 68 | — |
| Dexamethasone | 67 | 46 |
| Apixabanbrand: Eliquis | 62 | 12 |
| Ondansetron Hcl | 52 | 37 |
| Levothyroxine Sodium | 42 | 11 |
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-07-28
- Last updated
- 2025-03-19
- Certified
- 2025-03-19
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.